Flynn J C, Gardas A, Wan Q, Gora M, Alsharabi G, Wei W Z, Giraldo A A, David C S, Kong Y M, Banga J P
Department of Immunology and Microbiology, Wayne State University School of Medicine, Detroit, USA.
Clin Exp Immunol. 2004 Sep;137(3):503-12. doi: 10.1111/j.1365-2249.2004.02553.x.
Murine experimental autoimmune thyroiditis (EAT), characterized by thyroid destruction after immunization with thyroglobulin (Tg), has long been a useful model of organ-specific autoimmune disease. More recently, porcine thyroid peroxidase (pTPO) has also been shown to induce thyroiditis, but these results have not been confirmed. When (C57BL/6 x CBA)F(1) mice, recently shown to be susceptible to mouse TPO-induced EAT, were immunized with plasmid DNA to human TPO (hTPO) and cytokines IL-12 or GM-CSF, significant antibody (Ab) titres were generated, but minimal thyroiditis was detected in one mouse only from the TPO + GM-CSF immunized group. However, after TPO DNA immunization of HLA-DR3 transgenic class II-deficient NOD mice, thyroiditis was present in 23% of mice injected with TPO + IL-12 or GM-CSF. We also used another marker for assessing the closeness of the model to human thyroid autoimmunity by examining the epitope profile of the anti-TPO Abs to immunodominant determinants on TPO. Remarkably, the majority of the anti-TPO Abs was directed to immunodominant regions A and B, demonstrating the close replication of the model to human autoimmunity. TPO protein immunizations of HLA-DR3 transgenic mice with recombinant hTPO did not result in thyroiditis, nor did immunization of other mice expressing HLA class II transgenes HLA-DR4 or HLA-DQ8, with differential susceptibility to Tg-induced EAT. Moreover, our efforts to duplicate exactly the experimental procedures used with pTPO also failed to induce thyroiditis. The success of hTPO plasmid DNA immunization of DR3(+) mice, similar to our reports on Tg-induced thyroiditis and thyrotropin receptor DNA-induced Graves' hyperthyroidism, underscores the importance of DR3 genes for all three major thyroid antigens, and provides another humanized model to study autoimmune thyroid disease.
小鼠实验性自身免疫性甲状腺炎(EAT)以用甲状腺球蛋白(Tg)免疫后甲状腺破坏为特征,长期以来一直是器官特异性自身免疫性疾病的有用模型。最近,猪甲状腺过氧化物酶(pTPO)也被证明可诱发甲状腺炎,但这些结果尚未得到证实。当最近显示易患小鼠TPO诱导的EAT的(C57BL/6×CBA)F1小鼠用人类TPO(hTPO)和细胞因子IL-12或GM-CSF的质粒DNA免疫时,产生了显著的抗体(Ab)滴度,但仅在TPO+GM-CSF免疫组的一只小鼠中检测到轻微的甲状腺炎。然而,在用TPO DNA免疫HLA-DR3转基因II类缺陷型NOD小鼠后,23%注射TPO+IL-12或GM-CSF的小鼠出现了甲状腺炎。我们还通过检查抗TPO抗体针对TPO上免疫显性决定簇的表位谱,使用了另一种标记来评估该模型与人类甲状腺自身免疫的接近程度。值得注意的是,大多数抗TPO抗体针对免疫显性区域A和B,表明该模型与人类自身免疫的高度相似性。用重组hTPO对HLA-DR3转基因小鼠进行TPO蛋白免疫未导致甲状腺炎,对其他表达HLA II类转基因HLA-DR4或HLA-DQ8且对Tg诱导的EAT敏感性不同的小鼠进行免疫也未导致甲状腺炎。此外,我们精确重复使用pTPO的实验程序的努力也未能诱发甲状腺炎。DR3(+)小鼠hTPO质粒DNA免疫的成功,类似于我们关于Tg诱导的甲状腺炎和促甲状腺激素受体DNA诱导的格雷夫斯甲亢的报道,强调了DR3基因对所有三种主要甲状腺抗原的重要性,并提供了另一种用于研究自身免疫性甲状腺疾病的人源化模型。